It’s not the first question a parent asks. It’s likely not the fourth or fifth. But for parents like Brian and Diane Vollmert, the question of how to pay for their son, Scott, to receive the best care while providing for their family became an unmanageable challenge.
“From the very beginning, Scott didn’t fit cleanly in any category. He wasn’t clearly autistic. He wasn’t clearly developmentally delayed. He had characteristics of both,” said Diane. That combination of Autism Spectrum Disorder and developmental delay can add up to more than $2.4 million in care over Scott’s lifetime, according to a study published in the Journal of the American Medical Association’s Pediatrics last year. An astronomical sum for most Americans, including the Vollmerts.
To view the Multimedia News Release, go to http://www.multivu.com/players/English/7422152-northwestern-mutual-special-needs/
Today, MedImmune Specialty Care division of AstraZeneca (MedImmune Specialty Care) announced it has joined with actress Tia Mowry to raise awareness about the importance of an annual flu vaccination. To kick-off the campaign, MedImmune Specialty Care and Mowry unveiled an online video, “I Insist!” (www.YouTube.com/InsistOnTheMist), which uses comedy to educate busy families about the importance of living a healthy lifestyle and making flu vaccination a priority. For Mowry, this includes vaccination with FluMistQuadrivalent, the first and only FDA-approved needle-free flu vaccine for eligible persons 2-49 years old. FluMist Quadrivalent is administered as a gentle mist sprayed into the nose, where the influenza virus usually enters the body.
To view Multimedia News Release, go to http://www.multivu.com/mnr/63079-medimmune-specialty-care-tia-mowry-flumist-quadrivalent-encourage-flu-shot
Carnival Corporation & plc (NYSE/LSE: CCL; NYSE: CUK), the world’s largest leisure travel company, today announced an expansion of its O·C·E·A·N™ original content portfolio with the premiere of “Good Spirits™” on FYI™ beginning Thursday, February 16 at 6 p.m. ET and A&E® on February 20 at 2 p.m. ET.
“Good Spirits” joins pioneering cocktail chef Matthew Biancaniello as he sails the globe on the company’s world leading cruise lines in search of extraordinary everyday people, sharing the stories of spirits and collecting farm fresh, native ingredients to inspire one-of-a-kind cocktail creations.
The 30-minute, 10-episode series is the fourth originally produced program in Carnival Corporation’s growing portfolio of inspiring experiential content, following the debut of three TV series that currently air on major broadcast networks on Saturday mornings being viewed by millions each week.
To view the multimedia release go to:
http://www.multivu.com/players/English/8028351-carnival-a-e-networks-tv-series/
Emmy® and Tony® award-winning actress Blythe Danner and Amgen (NASDAQ:AMGN) today launch Act 2 Reduce Fractures™, an educational campaign for women with postmenopausal osteoporosis at increased risk for fractures. Earlier this year, Danner was diagnosed with postmenopausal osteoporosis at increased risk for fractures and wants to encourage women like her to educate themselves, take action and speak to their doctors to learn all they can about helping to strengthen their bones. The campaign is being supported by American Bone Health, the Global Healthy Living Foundation and the Older Women’s League.
To view Multimedia News Release, go to http://multivu.prnewswire.com/mnr/amgen/48052/
http://ummagma.bandcamp.com & http://www.ummagma.comUmmagma
is a Canadian-Ukrainian duo delivering an eclectic, harmonious
potpourri of sublime resonance, beats and rhythm. McLarnon’s delicate
airy gossamer-like vocals are often compared to Liz Fraser (Cocteau
Twins) with glimmers of Stereolab, The Sundays, Curve, Nathalie
Merchant and Slowdive. Kretov's spellbinding guitar, vocals, synths,
beats, programming & effects create soundscapes with elements of
Pink Floyd Peter Gabriel to help you take flight.Ummagma
won the 2013 Alternative Eurovision from 21 countries, and picked up 2
awards at the Australian Independent Music Video Awards. This duo has
regularly featured in The Scottish New Music Chart and had a full-page
feature in Rolling Stone Russia.http://www.facebook.com/ummagmahttp://www.soundcloud.com/ummagmahttp://www.youtube.com/ummagmahttp://twitter.com/ummagma
Today, Boehringer Ingelheim Pharmaceuticals, Inc. (BIPI) announced the launch of ‘Cuida tu Don,’ a national public awareness initiative featuring legendary entertainer Mario Kreutzberger, better known as ‘Don Francisco.’ Kreutzberger, who has type 2 diabetes, will serve as an ambassador for the initiative and encourage Hispanics with type 2 diabetes to live a lifestyle conducive to staying healthy. ‘Cuida tu Don,’ translated as ‘Take Care of Your Gift,’ is designed to engage, educate and inspire Hispanics with type 2 diabetes and their families. The initiative provides resources and information in three key aspects of diabetes – nutrition, fitness and treatment options – to the estimated 3.2 million Hispanics in the United States with the disease.
To view the Multimedia News Release, go to http://www.multivu.com/players/English/7401451-boehringer-ingelheim-diabetes/
Öğrenmede insan ile maymunlar arasındaki farkı çocuklar üzerinde değişik deneyler yaparak anlatan süper bir belgesel. İnsan maymundan daha ezberci gözüküyor, maymun anlamsız şeyleri insandan farklı olarak düşünerek yapmıyor, insan ise harfiyen yerine getiriyor. Bu insanlar için avantaj mı desavantyaj mı ? İzleyip görebilirsiniz.
A virus pits sister against sister one of them a Zombinista and the other Human. ZOMBIE POWER 2, where the fashionable and the dead combine. Available digitally on Amazon.com. Find out more at http://www.AnneElizabeth.net Comic book/comedy
Zensun Sci & Tech, Ltd., a biopharmaceutical company based in Shanghai and San Diego, announced today positive results of four completed Phase 2 clinical trials including three double-blind, placebo-controlled studies conducted in China and Australia and interim results from the United States Phase 2 trial for Zensun’s innovative “first-in-class” anti-heart failure drug, Neucardin™.
To view Multimedia News Release, go to http://www.multivu.com/mnr/61677-zensun-completes-clinical-trials-of-neucardin-treatment-of-heart-failure
